Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-006325

EVP and CFO sold 112,075 shares at an average $75.57 ($8,469,752)

  • EVP and CFO acquired 64,454 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brennan Daniel J. · EVP and CFO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-22 Exercise or conversion : show line 1 in the form 10b5-1 +16,863 $24.55 $413,987 288,405 D
2024-05-22 Exercise or conversion : show line 2 in the form 10b5-1 +16,863 $17.26 $291,055 305,268 D
2024-05-22 Exercise or conversion : show line 3 in the form 10b5-1 +15,642 $27.09 $423,742 320,910 D
2024-05-22 Exercise or conversion : show line 4 in the form 10b5-1 +15,086 $16.31 $246,053 335,996 D
2024-05-22 Sale : show line 5 in the form 10b5-1 −64,454 $75.91 $4,892,819 271,542 D
2024-05-23 Sale : show line 6 in the form 10b5-1 −47,621 $75.11 $3,576,932 223,921 D
Open-market sales · 112,075 sh · avg $75.57 · $8,469,752

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-05-22 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −15,642 46,927 D
2024-05-22 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −16,863 16,865 D
2024-05-22 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) −15,086 15,087 D
2024-05-22 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) −16,863 55,600 D
Loading xslF345X05/doc4.xml…